Protection by vitamin B2 against oxidant-mediated acute lung injury

Inflammation

Volumn 23, Issue 5, 1999, Pages 449-460

  Seekamp, Andreas ^a   Hultquist, Donald E ^b   Till, Gerd O ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN; COBROTOXIN; COMPLEMENT INHIBITOR; OXIDIZING AGENT; PHOTOSENSITIZING AGENT; SNAKE VENOM;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; DRUG EFFECT; INFLAMMATORY INFILTRATE; LUNG INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTECTION; RAT; ANIMAL; CATTLE; LONG EVANS RAT; LUNG; LUNG DISEASE; PATHOPHYSIOLOGY; REPERFUSION INJURY; VASCULARIZATION;

ANIMALS; CATTLE; COBRA VENOMS; COMPLEMENT INACTIVATOR PROTEINS; LUNG; LUNG DISEASES; MALE; OXIDANTS; OXIDATIVE STRESS; PHOTOSENSITIZING AGENTS; RATS; RATS, LONG-EVANS; REPERFUSION INJURY; RIBOFLAVIN;

EID: 0032589118     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021965026580     Document Type: Article

References (23)

1. 1. FANTONE, J. C., and P. A. WARD. 1982. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107:397-418.
2. 2. WARD, P. A., J. S. WARREN, and K. J. JOHNSON. 1988. Oxygen radicals, inflammation, and tissue injury. Free Radic. Biol. Med. 5:403-408.
3. 3. TILL, G. O., K. J. JOHNSON, R. KUNKEL, and P. A. WARD. 1982. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J. Clin. Invest. 89:126-135.
4. 4. JOHNSON, K. J., and P. A. WARD. 1981. Role of oxygen metabolites in immune complex injury of lung. J. Immunol. 126:2365-2369.
5. 5. SEEKAMP, A., M. S. MULLIGAN, G. O. TILL, and P. A. WARD. 1993. Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. Am. J. Pathol. 142:1217-1226.
6. 6. TILL, G. O., H. P. FRIEDL, and P. A. WARD. 1991. Lung injury and complement activation: role of neutrophils and xanthine oxidase. Free Radic. Biol. Med. 10:379-386.
7. 7. SUGIYAMA, M. 1992. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radic. Biol. Med. 12:397-407.
8. 8. OLSON, J. A., and S. KOBAYASHI. 1992. Antioxidants in health and disease: Overview. Proc. Soc. Exp. Biol. Med. 200:245-247.
9. 2-butyrate on the cardiac mitochrondrial disorders induced by adriamycin. J. Nutr. Sci. Vitaminol. 28:329-334.
10. 10. HULTQUIST, D. E., F. XU, K. S. QUANDT, M. SHLAFER, C. P. MACK, G. O. TILL, A. SEEKAMP, A. L. BETZ, and S. R. ENNIS. 1993. Evidence that NADPH-dependent methemoglobin reductase and administered riboflavin protect tissues from oxidative injury. Am. J. Hematol. 42:13-18.
11. 11. XU, F., and D. E. HULTQUlST. 1991. Coupling of dihydroriboflavin oxidation to the formation of the higher valence states of hemeproteins. Biochem. Biophys. Res. Commun. 181:197-203.
12. 12. XU, F., L. V. DEFILIPPI, D. P. BALLOU, and D. E. HULTQUIST. 1993. Hydrogen peroxide-dependent formation and bleaching of the higher oxidation states of bovine erythrocyte green heme protein. Arch. Biochem. Biophys. 301:184-189.
13. 13. HULTQUIST, D. E., C. P. MACK, K. S. QUAND, M. SCHLAFER, and F. XU. 1995. Studies of the mechanism by which riboflavin and pyrroloquinoline quinone protect tissues from re-oxygenation injury. The Oxygen Paradox (Davies, K. J. A. and Ursini, F., editors) pp. 731-745, CLEUP University Press, Padova, Italy.
14. 14. MACK, C. P., D. E. HULTQUIST, and M. SHLAFER. 1995. Myocardial flavin reductase and riboflavin: a potential role in decreasing reoxygenation injury. Biochem. Biophys. Res. Commun. 212:35-40.
15. 15. BETZ, A. L., X. D. REN, S. R. ENNIS, and D. E. HULTQUIST. 1994. Riboflavin reduces edema in focal cerebral ischemia. Acta Neurochir. (Suppl) 60:314-317.
16. 16. ALLAN, G., P. BHATTACHERJEE, C. D. BROOK, N. G. READ, and A. J. PARKE. 1985. Myeloper-oxidase activity as a quantitative marker of polymorpho-nuclear leukocyte accumulation into an experimental myocardial infarct: The effect of ibuprofen on infarct size and polymorphonuclear leukocyte accumulation. J. Cardiovasc. Pharmacol. 7:1154-1160.
17. 17. WARD, P. A., G. O. TILL, J. R. HATHERILL, T. M. ANNESLEY, and R. KUNKEL. 1985. Systemic complement activation, lung injury and products of lipid peroxidation. J. Clin. Invest. 76:517-527.
18. 18. YUBISUI, T., T. MATSUKI, K. TANISHTMA, M. TAKESHITA, and Y. YONEYAMA. 1977. NADPH-flavin reductase in human erythrocytes and the reduction of methemoglobin through flavin by the enzyme. Biochem. Biophys. Res. Commun. 76:174-179.
19. 19. PUNCH, J., R. REES, B. CASHMER, K. OLDHAM, E. WILKINS, and D. J. SMITH. 1991. Acute lung injury following reperfusion after ischemia in the hind limbs of rats. J. Trauma 31:760-765.
20. 2 release from vascular endothelial cells. Free Radic. Biol. Med. 14:217-223.
21. 21. PETRONE, W. F., D. K. ENGLISH, K. WONG, and J. M. MCCORD. 1980. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc. Natl. Acad. Sci. U.S.A. 77:1159-1163.
22. 22. PATEL, K. D., G. A. ZIMMERMAN, S. M. PRESCOTT, R. P. MCEVER, and T. M. MCINTYRE. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 12:749-759.
23. 23. GASIC, A. C., G. MCGUIRE, S. KRATER, A. I. FARHOOD, M. A. GOLDSTEIN, W. SMITH, M. L. ENTMAN, and A. A. TAYLOR. 1991. Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation 84:2154-2160.